Email This Release
EUSA Pharma宣布FDA核准Silvoximab治疗COVID-19相关急性呼吸窘迫综合征住院患者的3期临床试验
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: